Showing 121 - 140 results of 17,904 for search '(( significant i.e decrease ) OR ( significant ((step decrease) OR (a decrease)) ))', query time: 0.81s Refine Results
  1. 121
  2. 122
  3. 123

    Autapses play a crucial role in PV interneuron’s sustained firing at high frequencies. by Sara Hijazi (21656615)

    Published 2025
    “…Average action potential (AP) frequency in response to 0−650 pA current steps illustrating a significant increase in PV interneuron firing frequency at low-current steps in control cells without autapses (gray) compared to control cells with autapses (black). …”
  4. 124
  5. 125

    Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

    Published 2025
    “…In addition, inotodiol showed to induce apoptosis, characterized by an increase in Bax expression, a decrease in Bcl-2, Bcl-XL and MCL1 expression, the initiation of cleaved PARP1 and cleaved caspase 3, and inhibition of the MAPK/ERK pathway. …”
  6. 126
  7. 127
  8. 128

    Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate). by Manal A. Alossaimi (10269852)

    Published 2025
    “…<p>Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate).…”
  9. 129

    High Stability, Piezoelectric Response, and Promising Photocatalytic Activity on the New Pentagonal CGeP<sub>4</sub> Monolayer by José A. S. Laranjeira (18870824)

    Published 2024
    “…Notably, p-CGeP<sub>4</sub> has significant direct (<i>e</i><sub>31</sub> = −11.27 and <i>e</i><sub>36</sub> = −5.34 × 10<sup>–10</sup> C/m) and converse (<i>d</i><sub>31</sub> = −18.52 and <i>d</i><sub>36</sub> = −13.18 pm/V) piezoelectric coefficients, surpassing other pentagon-based structures. …”
  10. 130

    High Stability, Piezoelectric Response, and Promising Photocatalytic Activity on the New Pentagonal CGeP<sub>4</sub> Monolayer by José A. S. Laranjeira (18870824)

    Published 2024
    “…Notably, p-CGeP<sub>4</sub> has significant direct (<i>e</i><sub>31</sub> = −11.27 and <i>e</i><sub>36</sub> = −5.34 × 10<sup>–10</sup> C/m) and converse (<i>d</i><sub>31</sub> = −18.52 and <i>d</i><sub>36</sub> = −13.18 pm/V) piezoelectric coefficients, surpassing other pentagon-based structures. …”
  11. 131
  12. 132
  13. 133

    Does a correlation exist between delayed vaccination and a decreased vaccine confidence? by Virginia Reverte (9046494)

    Published 2024
    “…Online questionnaire was sent to their parents, followed by a telephone questionnaire for non-responders. Regarding MMR first dose, a significant association was found between delay and birth order and intellectual/motor delay of children. …”
  14. 134

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  15. 135

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  16. 136

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  17. 137

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  18. 138

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  19. 139

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  20. 140

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”